Extremely low and sustained HIV incidence among people who inject drugs in a setting of harm reduction

AIDS

Volumn 28, Issue 2, 2014, Pages 275-278

  Iversen, Jenny ^a   Wand, Handan ^b   Topp, Libby ^c   Kaldor, John ^b   Maher, Lisa ^a  

^a Viral Hepatitis Epidemiology and Prevention Program   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c CANCER RESEARCH DIVISION   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ARTICLE; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DISEASE TRANSMISSION; EPIDEMIC; FEMALE; FOLLOW UP; HARM REDUCTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; NEEDLE; PEOPLE WHO INJECT DRUG; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEROCONVERSION; SYRINGE;

AUSTRALIA; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DISEASE TRANSMISSION, INFECTIOUS; FEMALE; HARM REDUCTION; HIV INFECTIONS; HUMANS; INCIDENCE; MALE; RETROSPECTIVE STUDIES; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 84892373298     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000068     Document Type: Article

References (24)

1. Mathers BM, Degenhardt L, Phillips B, Wiessing L, Hickman M, Strathdee SA, et al. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet 2008; 372:1733-1745.
2. Wolfe D, Carrieri MP, Shepard D. Treatment and care for injecting drug users with HIV infection: a review of barriers and ways forward. Lancet 2010; 376:355-366.
3. Pisani E, Lazzari S, Walker N, Schwartlander B. HIV surveillance: a global perspective. J Acquir Immune Defic Syndr 2003; 32 (Suppl 1):S3-S11.
4. van Beek I, Dwyer R, Dore GJ, Luo K, Kaldor JM. Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study. BMJ 1998; 317:433-437.
5. Crofts N, Aitken CK. Incidence of bloodborne virus infection and risk behaviours in a cohort of injecting drug users in Victoria, 1990-1995. Med J Aust 1997; 167:17-20.
6. Guy RJ, McDonald AM, Bartlett MJ, Murray JC, Giele CM, Davey TM, et al. Characteristics of HIV diagnoses in Australia, 1993-2006. Sexual Health 2008; 5:91-96.
7. Strathdee SA, Stockman JK. Epidemiology of HIV among injecting and noninjecting drug users: current trends and implications for interventions. Curr HIV/AIDS Rep 2010; 7: 99-106.
8. Tempalski B, Lieb S, Cleland CM, Cooper H, Brady JE, Friedman SR. HIV prevalence rates among injection drug users in 96 large US metropolitan areas, 1992-2002. J Urban Health 2009; 86:132-154.
9. MacDonald M, Wodak AD, Ali R, Crofts N, Cunningham PH, Dolan KA, et al. HIV prevalence and risk behaviour in needle exchange attenders: a national study. The Collaboration of Australian Needle Exchanges. Med J Aust 1997; 166:237-240.
10. Iversen J, Wand H, Topp L, Kaldor J, Maher L. Reduction in HCV incidence among injection drug users attending needle and syringe programs in Australia: a linkage study. Am J Public Health 2013; 103:1436-1444.
11. Wand H, Yan P, Wilson D, McDonald A, Middleton M, Kaldor J, et al. Increasing HIV transmission through male homosexual and heterosexual contact in Australia: results from an extended back-projection approach. HIV Med 2010; 11:395-403.
12. Mehta SH, Galai N, Astemborski J, Celentano DD, Strathdee SA, Vlahov D, et al. HIV incidence among injection drug users in Baltimore, Maryland (1988-2004). J Acquir Immune Defic Syndr 2006; 43:368-372.
13. Bruneau J, Daniel M, Abrahamowicz M, Zang G, Lamothe F, Vincelette J. Trends in human immunodeficiency virus incidence and risk behavior among injection drug users in montreal, Canada: a 16-year longitudinal study. Am J Epidemiol 2011; 173:1049-1058.
14. van der Knaap N, Grady BP, Schim van der Loeff MF, Heijman T, Speksnijder A, Geskus R, et al. Drug users in Amsterdam: are they still at risk for HIV? PLoS One 2013; 8:e59125.
15. Kerr T, Small W, Buchner C, Zhang R, Li K, Montaner J, et al. Syringe sharing and HIV incidence among injection drug users and increased access to sterile syringes. Am J Public Health 2010; 100:1449-1453.
16. Roy E, Richer I, Morissette C, Leclerc P, Parent R, Claessens C, et al. Temporal changes in risk factors associated with HIV seroconversion among injection drug users in eastern central Canada. AIDS 2011; 25:1897-1903.
17. Mathers BM, Degenhardt L, Ali H, Wiessing L, Hickman M, Mattick RP, et al. HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage. Lancet 2010; 375:1014-1028.
18. Feachem R. Valuing the past-investing in the future: evaluation of the National HIV/AIDS Strategy 1993-94 to 1995-96. Canberra: Commonwealth Department of Human Services and Health; 1995.
19. Razali K, Thein HH, Bell J, Cooper-Stanbury M, Dolan K, Dore G, et al. Modelling the hepatitis C virus epidemic in Australia. Drug Alcohol Depend 2007; 91:228-235.
20. Kent CK, Chaw JK, Kohn RP, Chen YQ, Klausner JD. Studies relying on passive retrospective cohorts developed from health services data provide biased estimates of incidence of sexually transmitted infections. Sex Transm Dis 2004; 31:596-600.
21. Kellogg TA, Loeb L, Dilley J, Adler B, Louie BT, McFarland W. Comparison of three methods to measure HIV incidence among persons seeking voluntary, anonymous counseling and testing. J Acquir Immune Defic Syndr 2005; 39:112-120.
22. Topp L, Iversen J, Wand H, Day C, Kaldor J, Maher L. Representativeness of injecting drug users who participate in HIV surveillance: results from Australia's Needle and Syringe Program Survey. J Acquir Immune Defic Syndr 2008; 47:632-638.
23. Elliott JH, Mijch AM, Street AC, Crofts N. HIV, ethnicity and travel: HIV infection in Vietnamese Australians associated with injecting drug use. J Clin Virol 2003; 26:133-142.
24. Higgs P, Yohannes K, Hellard M, Maher L. Factors influencing a self-limiting HIV outbreak among ethnic Vietnamese injecting drug users in Melbourne, Australia. Qual Health Res 2009; 19:1690-1701.